PodParley PodParley
GPH 46: Life Course Epidemiology

EPISODE · Mar 22, 2026 · 59 MIN

GPH 46: Life Course Epidemiology

from Clinical Deep Dives · host Dr Manaan Kar Ray

In this episode, Medlock Holmes steps away from snapshots of disease and instead examines the long arc of health across an entire lifetime.Life course epidemiology asks a transformative question: How do exposures at different stages of life influence later health outcomes? Health is not merely the product of present conditions - it is layered, cumulative, and shaped by timing.Holmes explores three central conceptual models:* Critical period model - where exposures during specific windows (e.g., in utero, early childhood) have lasting effects.* Accumulation model - where risk builds progressively over time.* Pathway (or chain-of-risk) model - where early exposures influence later trajectories indirectly.We examine examples that illustrate these principles:* Fetal programming and adult cardiovascular disease* Childhood adversity and adult mental health* Socioeconomic disadvantage and chronic disease accumulation* Intergenerational transmission of riskHolmes also discusses methodological challenges: long follow-up periods, cohort attrition, measurement consistency, and disentangling age, period, and cohort effects.This episode reframes public health from reactive treatment to strategic timing. Prevention may begin decades before disease appears.Life course epidemiology reminds us that timing is as important as exposure.Key Takeaways* Health outcomes are shaped across the entire lifespan.* Critical periods represent windows of heightened biological sensitivity.* Risk may accumulate progressively over time.* Early exposures can influence later life trajectories indirectly.* Age, period, and cohort effects must be analytically distinguished.* Longitudinal study designs are central to life course research.* Early intervention may yield the greatest long-term benefit. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

GPH 46: Life Course Epidemiology

0:00 59:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!